Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend and speak at the Fortune Leaders Forum in Macao on September 8. (IMAGE)

InSilico Medicine

Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend and speak at the Fortune Leaders Forum in Macao on September 8.

Caption

As an innovative practitioner in AI drug discovery, Dr. Ren will articulate how Insilico leverages artificial intelligence to revolutionize traditional drug development paradigms—accelerating breakthrough therapies from the lab to the clinic with greater efficiency and reduced costs. He will also share how AI-driven biopharmaceutical innovation unleashes long-term value across Greater China and global capital markets, grounded in Insilico’s strategic footprint in the Guangdong-Hong Kong-Macao Greater Bay Area and globally.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.